In patients with medlinkchronic kidney disease/medlink, irreversible disease progression is triggered by the loss of podocytes, essential components...

MONDAY, Oct. 28, 2024 -- Empagliflozin continues to offer cardiorenal benefits for up to 12 months after discontinuation among patients with chronic...

A groundbreaking study by the National Institutes of Health (NIH) and collaborators has uncovered a major genetic risk factor for kidney disease among...

MONDAY, Oct. 28, 2024 -- The weight-loss drug Ozempic can guard against kidney disease in obese people, a new study shows. Patients taking semaglutide...

A study published in Clinical Cancer Research confirmed that tissue stiffening in the most common types of breast cancer, HER2-negative, can directly...

IgA nephropathy (IgAN) is an autoimmune kidney disease driven by immune cells that express a protein called CD38 on their surface.

Prior efforts to identify novel kidney biomarkers as risk factors for chronic kidney disease (CKD) progression have typically evaluated proteins...

Researchers investigate the clinical efficacy of semaglutide in controlling urine albumin-to-creatinine ratio in overweight patients with chronic...

Cleveland Clinic's virtual yoga program offers relief for chronic low back pain, combining accessibility with therapeutic benefits to help patients...

Fast-Mimicking Diet (FMD) allows limited food intake to mimic fasting benefits, promoting weight loss, reducing inflammation, and enhancing...